Ohio State University Clinical Research Stays on a Roll with Record Foundation Gift of $10m

Feb 29, 2020 | Cancer Research, Funds, Grants, Midwest, Ohio State University, Research

Ohio State University Clinical Research Stay on a Roll with Record Foundation Gift of $10m

Ohio State University research endeavors benefit from a $10 million gift from the Harry T. Mangurian Jr. Foundation—the largest gift ever—to support dementia and leukemia research, cancer drug development, health and wellness initiatives for student-athletes, and scholarships for business students.

A Generous Award

Ohio State University News reports that the Harry T. Mangurian Foundation will offer an incredibly generous gift to Ohio State University (OSU) to support important health-related research. OSU president Michael V. Drake stated: “We are deeply grateful for how this gift advances this important work and creates bright futures for patients, students and student-athletes alike.”

A Growing Research Force

Just recently, TrialSite News discussed OSU and the growing force they represent in clinical research. Ranking 42nd in NIH funding, the Buckeyes secured $137.9 million in NIH funding last year.

The Grants

The awards include $5 million to the Interdisciplinary Research Facility in the new West Campus Innovation District. This proposed five-story, 305,000 square-foot laboratory will serve multiple research disciplines from biomedical and life sciences to engineering and environmental and others. The facility will support both wet-lab and computational researchers and is planned to include the Pelotonia Institute for Immuno-Oncology.

The remaining $5 million will be divided equally among the following:

  • Drug Discoveries – accelerates cancer drug discoveries at The Ohio State University Comprehensive Cancer Center – Arthur G. James and Richard J. Solove Research Institute’s Drug Development Institute
  • Leukemia Research – supports medical research for leukemia, including additional clinical trials, developing novel synthetic microRNAs, and purchasing equipment.
  • Neurological Disease Research – supports science to advance new diagnostics and treatments for neurological conditions, including Lewy body and other dementias, gene therapy, and neuro-inflammation.
  • MBA Program – supports the Max M. Fisher College of Business partnership with the Drug Development Institute, including scholarships for business students focusing on drug development.
  • Health and Wellness – supports student-athlete health and wellness initiatives with Ohio State Athletics, including upgrading and replacing strength, conditioning, and biomechanics equipment and expanding the use of diagnostic, tracking, performance, and recovery tools and techniques.

This grant adds to previous gifts from this generous foundation that have gone to support brain and human performance research with athletics and OSU’s Neurological Institute, along with cancer drug development.

Who is the Mangurian Foundation?

Harry and Dorothy Mangurian established the Harry T. Mangurian, Jr. Foundation in 1999 to provide support to medical, educational, and environmental organizations nationally and internationally. Mangurian, a Florida businessman and former owner of the Boston Celtics, died of leukemia in 2008. His wife died in 2015 after being diagnosed with Lewy body dementia, the third most common form of dementia.


Pin It on Pinterest